BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8841087)

  • 21. Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine.
    Bhargava HN; Reddy PL; Gudehithlu KP
    Gen Pharmacol; 1995 Jan; 26(1):131-6. PubMed ID: 7713352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: reversal by naltrexone.
    Kumar S; Bhargava HN
    Gen Pharmacol; 1997 Aug; 29(2):223-7. PubMed ID: 9251903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum.
    Collins LM; Meyer JS
    Synapse; 1996 Aug; 23(4):335-43. PubMed ID: 8855519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
    Bhargava HN; Kumar S
    Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
    Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
    Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter.
    Zhen J; Maiti S; Chen N; Dutta AK; Reith ME
    Eur J Pharmacol; 2004 Dec; 506(1):17-26. PubMed ID: 15588620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
    Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
    Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
    Héron C; Billaud G; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat.
    Bhargava HN; Larsen AK; Rahmani NH; Villar VM
    Brain Res; 1993 Apr; 607(1-2):1-8. PubMed ID: 8481789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of substance P-ergic system in the rat spinal cord by an opioid antagonist.
    Igwe OJ
    Brain Res Mol Brain Res; 1994 Feb; 21(3-4):263-73. PubMed ID: 7513375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Bhargava HN; Rahmani NH
    Pharmacology; 1993; 46(2):75-81. PubMed ID: 8382821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
    Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
    Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
    J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
    Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
    Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
    Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction.
    Simantov R
    Neurosci Lett; 1993 Dec; 163(2):121-4. PubMed ID: 8309616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of postmortem modifications in synaptosomal [3H]dopamine uptake and [3H]GBR 12783 binding to the dopamine uptake complex in the rat striatum.
    Thibaut F; Bonnet JJ; Costentin J
    Neurosci Lett; 1989 Jan; 96(3):335-9. PubMed ID: 2717059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]GBR 12935 labels mainly the piperazine acceptor site in the rat prefrontal cortex.
    Gordon I; Weizman R; Rehavi M
    Brain Res; 1995 Mar; 674(2):205-10. PubMed ID: 7796098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
    Kula NS; Baldessarini RJ
    Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.